UBS Group AG - KINTARA THERAPEUTICS INC ownership

KINTARA THERAPEUTICS INC's ticker is KTRA and the CUSIP is 49720K101. A total of 22 filers reported holding KINTARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KINTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,000
+400.0%
49,437
+1422.1%
0.00%
Q2 2022$1,000
-50.0%
3,248
-18.8%
0.00%
Q1 2022$2,0000.0%3,9980.0%0.00%
Q4 2021$2,000
-33.3%
3,9980.0%0.00%
Q3 2021$3,000
-76.9%
3,998
-30.2%
0.00%
Q2 2021$13,000
+62.5%
5,726
+22.2%
0.00%
Q1 2021$8,000
+700.0%
4,687
+654.8%
0.00%
Q4 2020$1,000
-85.7%
621
-88.0%
0.00%
Q3 2020$7,0005,1880.00%
Other shareholders
KINTARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
swisspartners Ltd. 275,000$79,0000.08%
Affinity Capital Advisors, LLC 18,590$5,0000.00%
Nantahala Capital Management 116,234$32,0000.00%
Maltin Wealth Management, Inc. 10,000$3,0000.00%
OSAIC HOLDINGS, INC. 48,175$13,0000.00%
WELLS FARGO & COMPANY/MN 390$00.00%
NORTHERN TRUST CORP 44,142$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 358,026$99,0000.00%
STATE STREET CORP 116,074$32,0000.00%
View complete list of KINTARA THERAPEUTICS INC shareholders